Misfeldt Dayton
Insider CIK 1461466 · SNSS See Remarks, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2020-06-30 | 2020-07-01 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2020-03-31 | 2020-04-02 | 480,000 | — | $0 | 480,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2019-06-28 | 2019-07-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2019-06-28 | 2019-07-02 | 480,000 | — | $0 | 480,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2018-12-31 | 2019-01-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2018-06-29 | 2018-07-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2018-06-29 | 2018-07-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2017-12-29 | 2018-01-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy deriv | 2017-10-27 | 2017-10-30 | 196,260 | — | $0 | 196,260 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy deriv | 2017-10-27 | 2017-10-30 | 3,740 | — | $0 | 3,740 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-10-27 | 2017-10-30 | 392,520 | $2.00 | $785.0K | 1,598,260 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-10-27 | 2017-10-30 | 7,480 | $2.00 | $15.0K | 30,456 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2017-05-31 | 2017-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2016-06-30 | 2016-07-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2015-12-21 | 2015-12-21 | 32,725 | $0.84 | $27.5K | 137,859 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2015-12-21 | 2015-12-21 | 1,717,275 | $0.84 | $1.44M | 7,234,441 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-12-21 | 544,893 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-12-21 | 10,383 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-12-21 | 20,766 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-12-21 | 1,089,788 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-12-21 | 20,766 | $1.32 | $27.4K | 106,638 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-12-21 | 207,938 | $3.46 | $719.5K | 5,517,166 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-12-21 | 544,893 | $1.32 | $719.3K | 5,725,104 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-12-21 | 415,877 | $3.46 | $1.44M | 5,180,211 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-12-21 | 1,089,788 | $1.32 | $1.44M | 5,596,088 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-12-21 | 3,962 | $3.64 | $14.4K | 105,134 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-12-21 | 10,383 | $1.32 | $13.7K | 109,096 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-12-21 | 7,925 | $3.46 | $27.4K | 98,713 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2015-06-30 | 2015-07-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-28 | 2014-08-29 | 3,740 | $7.89 | $29.5K | 85,872 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-28 | 2014-08-29 | 196,260 | $7.89 | $1.55M | 4,506,300 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-27 | 2014-08-29 | 1,883 | $8.16 | $15.4K | 89,612 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-27 | 2014-08-29 | 98,817 | $8.16 | $806.3K | 4,702,560 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-12 | 2014-08-12 | 694 | $6.77 | $4.7K | 91,495 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-12 | 2014-08-12 | 36,406 | $6.77 | $246.5K | 4,801,377 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-11 | 2014-08-12 | 31,009 | $6.90 | $214.0K | 4,837,783 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-11 | 2014-08-12 | 591 | $6.90 | $4.1K | 92,189 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-08 | 2014-08-12 | 662,378 | $6.62 | $4.38M | 4,868,792 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-08 | 2014-08-12 | 12,622 | $6.62 | $83.6K | 92,780 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2014-06-30 | 2014-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2013-06-28 | 2013-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2012-06-29 | 2012-07-02 | 25,000 | — | $0 | 25,000 | SEC↗ |